Management of Polycystic Ovarian Syndrome

Management of polycystic ovarian syndrome with homoeopathic intervention versus standard conventional treatment -A non-randomised comparative study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/10/028282

Enrollment

140

Registered

2020-10-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Homoeopathic Intervention and Standard conventional treatment is comparator: Intervention medicines will be administered orally. The medicine will be repeated depending on the potency

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female aged 18 to 36 years 2. Oligomenorrhea/amenorrhea (two years after menarche) 3. Ultrasound findings of Polycystic ovaries 4. Clinical evidence of acne (acne global severity scale score 1 and above) 5. Written Informed consent from the patient

Exclusion criteria

Exclusion criteria: 1. History of DM, Cushing disease, hyperprolactinemia, untreated hypo or hyperthyroidism, adrenal hyperplasia and adrenal tumor 2. Ovarian tumor, hyperthecosis and significant renal impairment 3. History of intake of drugs aldactone or metformin or history of OCP use or intake of drugs known to interfere with carbohydrate metabolism prior 4 weeks before enrolment. 4. Pregnancy, breast feeding 5. Cases with other systemic diseases or infections or on other treatment therapies

Design outcomes

Primary

Measure	Time frame
Establishment of regular menstrual cycle along with either ultrasonological improvement of PCO or improvement in acneTimepoint: 6 months	—

Secondary

Measure	Time frame
To compare the changes in domain scores of PCOSQ in both homoeopathic group and conventional treatment group at monthly interval for 6 months.Timepoint: 6 months;To compare the changes in insulin resistance through HOMA-IR in two groups.Timepoint: 6 months;To compare the changes in ultrasound reports of PCO at entry and 6 months in homoeopathy and conventional groups.Timepoint: 6 months;To compare the pregnancies achieved in cases of infertility in homoeopathy and conventional intervention groupsTimepoint: 6 months	—

Measure

Time frame

To compare the changes in domain scores of PCOSQ in both homoeopathic group and conventional treatment group at monthly interval for 6 months.Timepoint: 6 months;To compare the changes in insulin resistance through HOMA-IR in two groups.Timepoint: 6 months;To compare the changes in ultrasound reports of PCO at entry and 6 months in homoeopathy and conventional groups.Timepoint: 6 months;To compare the pregnancies achieved in cases of infertility in homoeopathy and conventional intervention groupsTimepoint: 6 months

—

Countries

India

Contacts

Public ContactDr Chetna Deep Lamba

Central Council for Research in Homoeopathy

oberai.praveen@gmail.com9811952274

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026